A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio(Human Technopole), Mathew J. Garnett(Wellcome Sanger Institute), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Syd Barthorpe(Wellcome Sanger Institute), David Tamborero(Universitat Pompeu Fabra), Xianming Deng(Xiamen University), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Nathanael S. Gray(Stanford University), Thomas Cokelaer(European Bioinformatics Institute), Daniel A. Haber(Howard Hughes Medical Institute), Xeni Mitropoulos(Harvard University), Laura Richardson(Wellcome Sanger Institute), Ewald van Dyk(The Netherlands Cancer Institute), Michael P. Menden(Biotechnology Institute), Regina K. Egan(Harvard University), Michaël Schubert(Innsbruck Medical University), Núria López-Bigas(Duran i Reynals Hospital), Sebastián Morán(Institut d'Investigació Biomédica de Bellvitge), Michael R. Stratton(Wellcome Sanger Institute), Cyril H. Benes(Harvard University), Howard Lightfoot(Wellcome Sanger Institute), Graham R. Bignell(Lund University), Heshani de Silva(Bristol-Myers Squibb (United States)), Emanuel Gonçalves(European Bioinformatics Institute), Holger Heyn(Scope Group (United States)), Tatiana Mironenko(Wellcome Sanger Institute), Nanne Aben(The Netherlands Cancer Institute), Ultan McDermott(AstraZeneca (United Kingdom)), Maryam Soleimani(Wellcome Sanger Institute), Sergi Sayols(Institute of Molecular Biology), Theo Knijnenburg(North Seattle College), Patricia Greninger(Harvard University), Daniël J. Vis(The Netherlands Cancer Institute), Jinhua Wang(Harvard University), Han Chang(Bristol-Myers Squibb (United States)), Tinghu Zhang(Stanford University), Julio Sáez-Rodríguez(European Bioinformatics Institute), Qingsong Liu(Medical College of Wisconsin), Petra Ross‐Macdonald(Bristol-Myers Squibb (United States))
Cited by 2,259
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
|Nature|2007|5.3k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k